You searched for "CXL"
Combined PRK and CXL in keratoconus
1 June 2019
| Inderpaul S Sian
|
Cataract and Refractive
This study aimed to investigate the results after photorefractive keratectomy (PRK) followed immediately by standard 30-minute corneal cross-linking (CXL) for keratoconus. This retrospective study included 26 eyes of 16 patients with keratoconus. Uncorrected distance visual acuity (UDVA), corrected distance visual...
KXL is CXL
The KXL cross-linker speeds up the CXL process dramatically. The whole procedure can be completed in 14 minutes, resulting in substantial time savings for the surgeon. Two new riboflavin formulations – Trans-Epi and Vibex Rapid – allow expanded and more...Outcomes of corneal collagen crosslinking (CXL) in pseudophakic bullous keratopathy (PBK)
1 August 2014
| Sharmina Khan
|
Cornea / External Eye Disease
This was a retrospective non-comparative, interventional case series of 50 eyes in 50 patients with symptomatic PBK who underwent CXL (epithelium-off). Central corneal thickness (CCT), pain score, best corrected visual acuity (BCVA), and corneal transparency were recorded at baseline; at...
Repeat corneal collagen cross-linking after failure of primary cross-linking (CXL) in keratoconus
3 October 2024
| Jonathan Chan
|
Cornea / External Eye Disease
This is a 10-year, retrospective, patients record review from Leeds, UK. Twenty-one eyes had repeated CXL and the mean interval between primary and repeat CXL was 47.1 months. Twenty (95%) eyes stabilised after repeated CXL at a mean follow-up of...
Conventional vs. accelerated cross-linking
1 August 2016
| Anjali Gupta
|
Cornea / External Eye Disease
|
accelerated corneal collagen cross-linking, corneal collagen cross-linking, keratoconus
The Dresden protocol of 3mW/cm2 irradiance for 30 minutes has been extensively studied and has shown advantageous clinical and topographical results. However, this protocol is time-consuming and therefore accelerated CXL using higher irradiance to shorten treatment duration has emerged. The...
Corneal Collagen Cross-Linking
1 June 2016
| Shirley Hancock
|
EYE - Cornea
As the title suggests, this publication provides a single volume that collates much of the current knowledge and application for corneal collage cross-linking (CXL). There are 23 chapters, subdivided into seven sections, including five pages of indices. The chapters are...
Corneal crosslinking in pellucid marginal degeneration
1 April 2020
| Su Young
|
Cornea / External Eye Disease
Fourteen studies were included in this first review examining the use of corneal-crosslinking (CXL) to treat pellucid marginal degeneration (PMD). PMD is a bilateral, non-inflammatory corneal thinning disorder characterised by inferior peripheral corneal thinning 1-3mm from the limbus in the...
Corneal cross-linking for treatment of corneal ulcers
1 February 2019
| Bushra Thajudeen
|
Cornea / External Eye Disease
This was an observational cohort study looking at the usefulness of photo activated chromophore for infectious keratitis-corneal collagen cross-linking (PACK-CXL) in reducing the time to heal in suppurative corneal ulcers. This study, conducted in a tertiary care centre in South...
The impact of collagen crosslinking on keratoplasty numbers in keratoconics
1 October 2015
| Magdalena Popiela
|
Cornea / External Eye Disease
A question of corneal cross-linking (CXL) reducing keratoplasty numbers in keratoconics was addressed in this single centre observational study from the Oslo University Hospital – a sole provider of keratoplasties and CXL for a population of 2.8 million. Authors compared...
Results of corneal cross-linking in very steep corneas
1 February 2019
| Bushra Thajudeen
|
Cornea / External Eye Disease
Corneal cross-linking (CXL) has been shown to be a safe and valid treatment option for progressive keratoconus and have shown an arrest of progression with a low failure rate of 0% to 2.8% in mild to moderate keratoconus. A Kmax...
Outcomes of corneal cross-linking in paediatric patients compared to fellow untreated eyes
1 October 2018
| Bushra Thajudeen
|
Cornea / External Eye Disease
This retrospective cohort study evaluated long-term visual, refractive, topographic and safety outcomes of corneal cross-linking (CXL) in patients younger than 18-years-old with keratoconus. The study included all consecutive paediatric patients who underwent epithelium-off CXL treatment for keratoconus at the study...
PACK-crosslinking for infectious keratitis
1 October 2015
| David Tabibian, Farhad Hafezi
|
EYE - Cornea
Corneal cross-linking with riboflavin and UV-A light (CXL) is a technology that has been initially developed to treat corneal ectatic disorders [1]. Its effect in stabilising diseases such as keratoconus was reported in numerous trials with excellent long-term outcomes and...